Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
aUroCell-Tx
- Development stage
- Preclinical
- Lead developer
- Phosprint
- Modality
- Hematopoietic Stem Cells → Adult Stem Cells → Stem Cell Therapies → Cell Therapies, Patient-derived iPSCs → iPSCs → Pluripotent Stem Cells → Stem Cell Therapies → Cell Therapies, Autologous CAR-T → CAR-T Cells → Engineered T Cells → Adoptive Cell Transfer → Cell Therapies, Mesenchymal Stem Cells → Adult Stem Cells → Stem Cell Therapies → Cell Therapies, Tumor-Infiltrating Lymphocytes (TILs) → Native Immune Cells → Adoptive Cell Transfer → Cell Therapies
- Administration
- Intravesical
01
Overview
aUroCell-Tx is an autologous cell therapy product developed by Phosprint P.C. for the treatment of bladder cancer, specifically muscle-invasive bladder cancer (MIBC). The therapy utilizes a proprietary Laser-Induced Forward Transfer (LIFT) technology to precisely print a patient's own urothelial cells onto the bladder wall. This bioprinting approach is intended to regenerate the urothelium and repair the bladder wall following surgical procedures like transurethral resection of bladder tumor (TURBT), thereby reducing the risk of cancer recurrence and progression. By employing autologous cells, the treatment aims to avoid immune rejection while providing a localized, regenerative therapeutic effect within the bladder environment.
- Other names
- Autologous urothelial cell neobladderIn-vivo laser bioprinting neobladder
Beyond the preview
Go deeper on aUroCell-Tx.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on aUroCell-Tx.